Source: Eur Respir J 2004; 24 : 703-707
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Minder S., Fischler M., Muellhaupt B., Zalunardo M.P., Jenni R., Clavien P-A., Speich R.. Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension. Eur Respir J 2004; 24 : 703-707

Member's Comments

No comment yet.

Related content which might interest you: Sildenafil for patients with portopulmonary hypertension, candidates to hepatic transplant Source: Eur Respir J 2004; 24: Suppl. 48, 109s Year: 2004 Resolution of portopulmonary hypertension (POPH) following liver transplantation Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Experience with inhaled iloprost and bosentan in portopulmonary hypertension Source: Eur Respir J 2007; 30: 1096-1102 Year: 2007 Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease Source: Eur Respir J 2009; 34: 1348-1356 Year: 2009 Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview Source: Eur Respir Rev 2012 21:223-233 Year: 2012 Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung Source: Eur Respir J 2003; 21: 192-194 Year: 2003 Association between portopulmonary hypertension and hepatopulmonary syndrome in cirrhotics, candidates to hepatic transplantation Source: Annual Congress 2003 - Pulmonary hypertension Year: 2003 The hepatopulmonary syndrome Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=112 Year: 2005 Liver transplantation in hepatopulmonary syndrome and portopulmonary hypertension Source: Annual Congress 2003 - Pulmonary-hepatic disorders (PHD) - recommendations of the PHD ERS Task Force for management of hepatopulmonary syndrome and portopulmonary hypertension Year: 2003 Outcome of candidates for liver transplantation suffering from portopulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Portopulmonary hypertension Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=129 Year: 2005 The prevalence of pulmonary hypertension in cirrhotic patients submitted to hepatic transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 465s Year: 2003 Sildenafil treatment for portopulmonary hypertension Source: Eur Respir J 2006; 28: 563-567 Year: 2006 The lung in liver disease: hepatopulmonary syndrome and portopulmonary hypertension Source: Eur Respir Monogr 2019; 86: 262-277 Year: 2019 Portopulmonary hypertension: a consequence of portal hypertension Source: Eur Respir Mon 2012; 57: 58-70 Year: 2012 Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation Source: Eur Respir J 2012; 39: 1520-1533 Year: 2012 Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant Source: Eur Respir J 2007; 30: 715-721 Year: 2007 Iloprost treatment in portopulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension Source: Eur Respir J 2013; 41: 96-103 Year: 2013 Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015